Navigation Links
Combined mammography and breast MRI useful for some high-risk women
Date:2/22/2010

OAK BROOK, Ill. Annual breast cancer screening with both mammography and magnetic resonance imaging (MRI) is likely to be a cost-effective way to improve life expectancy in women with an increased risk of breast cancer, according to a new study published in the March issue of Radiology. The findings support current American Cancer Society screening recommendations.

"For women at the highest risk of breast cancer, using both breast MRI and mammography together for screening will likely reduce their chances of dying from breast cancer and help them live longer, healthier lives," said the study's lead author, Janie M. Lee, M.D., radiologist from Massachusetts General Hospital in Boston.

Women with certain mutations in the BRCA1 gene have a significantly increased lifetime risk of developing breast cancer. Mammography, the current standard for breast cancer screening in the general population, detects fewer than half of breast cancers in these high-risk women, in part because their younger age at screening and associated increased breast density make visualizing tumors challenging.

While breast MRI is a useful adjunct to mammography for screening women at increased genetic risk of breast cancer, it is more time consuming and expensive than mammography and has a higher incidence of false-positive findings.

For the study, Dr. Lee and colleagues compared the costs and benefits of film mammography, of MRI and of combined mammography and MRI in a hypothetical group of 25-year-old women with BRCA1 mutations.

The researchers used statistical modeling to estimate the number of quality adjusted life years (QALYs) gained by screening, along with lifetime costs. QALYs are a measure of both the quantity and quality of life.

Women undergoing annual combined screening with both mammography and MRI gained 49.62 QALYs at a cost of $110,973. Annual MRI screening alone provided 49.50 QALYs at a cost of $108,641, while annual mammography alone provided 44.46 QALYs at a cost of $100,336.

Adding annual MRI to annual mammography screening cost $69,125 for each additional QALY gained. Although there is no consensus in the U.S. on what constitutes a cost-effective intervention, commonly cited threshold values range from $50,000 to $100,000 per QALY, according to Dr. Lee.

Annual combined screening was best at detecting early stage cancers and provided the greatest relative mortality reduction. Combined screening became more cost-effective as breast cancer risk increased, and less cost-effective as risk decreased.

MRI screening was associated with an increase in false-positive results. Annual mammography resulted in 37 false-positive screening examinations for every breast cancer death averted. The addition of annual MRI increased the number of false-positive results to 137 for each breast cancer death averted.

"The benefits provided by MRI are balanced by an increased chance of needing additional tests to evaluate a possible abnormality, and perhaps even a biopsy that might in the end show no cancer," Dr. Lee said.


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Study Finds New Version of QIAGENs HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment
2. Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
3. Combined Boards Provide Better Care to More Clients More Efficiently
4. Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
5. Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors
6. AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals
7. Combined stenting and photodynamic therapy improves survival in late stage liver cancer patients
8. USC researchers find benefit for lymphoma patients in combined PET-CT scanning
9. Home Oxygen Leaders Warn That Competitive Bidding Program Reductions Combined with Other Pending and Proposed Cuts Are Unsustainable and Unpredictable
10. Combined physical and genetic map finds cancers ignition key
11. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Award-winning medical group Allied Anesthesia today ... board chair for Orange County health care system CalOptima Friday. CalOptima announced its ... chair Mark Refowitz’s term, which runs through June 30 of this year, until ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ... Success website has recently developed and published an informational resource that addresses frequently ... based on common inquiries the site’s team of third party administrator (TPA) contributors ...
(Date:3/28/2017)... Monica, CA (PRWEB) , ... March 28, 2017 ... ... Dr. Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the ... gastric balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s already ...
(Date:3/28/2017)... ... 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ages, ... to offer to the discussion of dealing with excess skin oil. “Oily skin is a ... remedies that can help remove the oily shine while keeping the skin fresh and clean,” ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... New patients ... Braasch for leading sleep apnea treatment, with or without a referral. Sleep apnea is ... which can include daytime sleepiness, morning headaches and chronic snoring. , Dr. Braasch ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CAMBRIDGE, Mass. , March 28, 2017  Akcea Therapeutics, ... three additions to the company,s board of directors: ... Bessemer Venture Partners. Mr. Gabrieli will serve as chairman of ... Hochberg , former chief commercial officer of Forest Laboratories. ... of Global Biolink Partners. "We are ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
(Date:3/28/2017)... , March 28, 2017 The ... to reach a value of USD 4.5 billion by ... Research, Inc. Proper closure of injured tissues post operation ... function. Postoperative leakages occur in 3% to 15% of ... are responsible for one third of postoperative deaths in ...
Breaking Medicine Technology: